全、新、优、品、好四大特点：

凝血酶(凝血因子II)轻链抗体品牌 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

凝血酶(凝血因子II)轻链抗体品牌 英文名称  Anti-Thrombin light chain

中文名称  凝血酶(凝血因子II)轻链抗体品牌 

别    名 coagulation factor II; prothrombin; F2; Cf-2; Cf2; FII; F 2; coagulation factor II (thrombin); Coagulation factor II; Coagulation factor II precursor; F2; Factor II; Factor-II; Prothrombin; prothrombin B-chain; PT; serine protease; THRB; THRB_HUMAN; Thrombin; Thrombin light chain.

产品属性：

浓    度  1mg/1ml

规 格  0.1ml/100μg 0.2ml/200μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, Guinea Pig

产品类型   一抗  

研究领域    心 细胞生物 激酶和磷酸酶 合成与降解

蛋白分子量  predicted molecular weight: 4/64kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated synthetic peptide derived from human Thrombin light chain

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

凝血酶(凝血因子II)轻链抗体品牌 产品应用   WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 Thrombin is the final protease in the blood coagulation cascade and serves both pro- and anticoagulant functions through the cleavage of several targets. The ability of thrombin to specifically recognize a wide range of substrates derives from interactions which occur outside of the active site of thrombin. Thrombin possesses two anion binding exosites which mediate many of its interactions with cofactors and substrates, and although many structures of thrombin have been solved, few such interactions have been described in molecular detail. Glycosaminoglycan binding to exosite II of thrombin plays a major role in switching off the procoagulant functions of thrombin by mediating its irreversible inhibition by circulating serpins and by its binding to the endothelial cell surface receptor thrombomodulin.

Function : Thrombin is an active enzyme in the earliest steps of the blood clot formation, generated from its circulating inactive precursor prothrombin. Thrombin is a glycoprotein formed by two peptides chains of 36 and 259 amino acids linked by disulfure bonds. Three important sites have been identified on the surface of the enzyme: The catalytic site that confers to the molecule its serine protease activity, the exosite one responsible for the binding of the substrate (fibrinogen or thrombin receptor) and the exosite two responsible for the binding of antithrombin III and inactivation of thrombin. Gamma Thrombin is a proteolyzed form of Alpha Thrombin. Gamma Thrombin consists of four chains (A, B1, B5, B4) with a disulfide link between the A peptide and the B5 peptide.

Subunit : Heterodimer (named alpha-thrombin) of a light and a heavy chain; disulfide-linked. Forms a heterodimer with SERPINA5.

Subcellular Location : Secreted, extracellular space.

Tissue Specificity : Expressed by the liver and secreted in plasma.

Post-translational modifications : The gamma-carboxyglutamyl residues, which bind calcium ions, result from the carboxylation of glutamyl residues by a microsomal enzyme, the vitamin K-dependent carboxylase. The modified residues are necessary for the calcium-dependent interaction with a negatively charged phospholipid surface, which is essential for the conversion of prothrombin to thrombin.

N-glycosylated. N-glycan heterogeneity at Asn-121: Hex3HexNAc3 (minor), Hex4HexNAc3 (minor) and Hex5HexNAc4 (major). At Asn-143: Hex4HexNAc3 (minor) and Hex5HexNAc4 (major).

DISEASE : Factor II deficiency (FA2D) [MIM:613679]: A very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels. Note=The disease is caused by mutations affecting the gene represented in this entry.

Ischemic stroke (ISCHSTR) [MIM:601367]: A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.

Thrombophilia due to thrombin defect (THPH1) [MIM:188050]: A multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation. Note=The disease is caused by mutations affecting the gene represented in this entry. A common genetic variation in the 3-prime untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis.

Pregnancy loss, recurrent, 2 (RPRGL2) [MIM:614390]: A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.

Similarity : Belongs to the peptidase S1 family.

Contains 1 Gla (gamma-carboxy-glutamate) domain.

Contains 2 kringle domains.

Contains 1 peptidase S1 domain.

Database links : UniProtKB/Swiss-Prot: P00734.2

实验流程：

正在热销的相关产品：

Anti-Trk B/FITC 荧光素标记酪氨酸激酶B抗体IgGMulti-class antibodies规格： 0.2ml

Tau protein 微管相关蛋白(抗原)Multi-class antibodies规格： 0.5mg

酪氨酸羟化酶抗体 Anti-TY3H/TH 0.1ml

phospho-SYN1(Ser9) 英文名称： 磷酸化神经突触素1抗体 0.1ml

EMP2 英文名称： 上皮细胞膜蛋白2抗体 0.1ml

Rhesus antibody Rh Phospho-INPPL1(Tyr986/987) 肌醇聚磷酸盐磷酸酶样蛋白1抗体 规格 0.1ml

Tau protein 微管相关蛋白(抗原)Multi-class antibodies规格： 0.5mg

Anti-Phospho-TIF1beta (Ser824)/FITC 荧光素标记磷酸化转录中介因子Tif1β抗体IgGMulti-class antibodies规格： 0.2ml

NPY ( Neuropeptide Y) 神经肽 Y(抗原)Multi-class antibodies规格： 0.5mg

磷酸化微管相关蛋白抗体 Anti-P-Tau protein 0.1ml

phospho-SYN1(Ser62+Ser67) 英文名称： 磷酸化神经突触素1抗体 0.1ml

phospho-Ephrin B (Tyr316) 英文名称： 磷酸化Ephrin B抗体 0.1ml

Rhesus antibody Rh Phospho-LKB1(Thr189) 磷酸化丝氨酸/苏氨酸蛋白激酶抗体 规格 0.1ml

NPY ( Neuropeptide Y) 神经肽 Y(抗原)Multi-class antibodies规格： 0.5mg

PAX9(Paired box gene 9) 配对盒基因9抗原Multi-class antibodies规格： 0.5mg

Anti-ATG7 自噬相关蛋白7抗体Multi-class antibodies规格： 0.2ml

Rhesus antibody Rh Phospho-AP2M1 (Thr156) 磷酸化接头相关蛋白复合体AP-2μ链1抗体 规格 0.1ml

PSA 1:150 浓缩液 0.1ml 进口分装

Ube2L6 英文名称： 泛素载体蛋白L6抗体 0.2ml

Dihydropyrimidinase 英文名称： 二氢嘧啶抗体 0.2ml

Anti-ATG7 自噬相关蛋白7抗体Multi-class antibodies规格： 0.2ml

IL4 Protein Mouse 重组小鼠 IL4 / Ierleukin-4 蛋白 (Q136D, Y139D, His 标签)

试剂耗材

HA Others H6N4 甲型 H6N4 (A/chicken/HongKong/17/77) 血凝素HA1 (Hemagglutinin) 人细胞裂解液 (阳性对照)

KB人口腔表皮样癌细胞 KB human oral epidermoid carcinoma cells MEM培养基(GIBCO)+10%FBSRPMI-1640(GIBCO)+10%FBS

CM-H028人淋巴内皮细胞完全培养基100mL

人表皮淋巴内管皮细胞(HDLEC)(5×105) 人星形胶质细胞 Human

CM-H093人颅盖造骨细胞完全培养基100mL

LILRB1 Others Human 人 LILRB1 / CD85 / ILT2 / ILR1 人细胞裂解液 (阳性对照)

人直肠平滑肌细胞HRSMC

Ca Ski细胞，人小肠颈部表皮样癌细胞 人癌细胞,ZR75-1细胞 狗间充质干细胞-脂肪DMSC-ad

牛肾细胞;MDBK(BVDV-free)

LCN2 Others Human 人 LCN2 / NGAL 人细胞裂解液 (阳性对照)

凝血酶(凝血因子II)轻链抗体品牌 IL4 Protein Mouse 重组小鼠 IL4 / Ierleukin-4 蛋白 (Q136D, Y139D, His 标签)

试剂耗材

HA Others H6N4 甲型 H6N4 (A/chicken/HongKong/17/77) 血凝素HA1 (Hemagglutinin) 人细胞裂解液 (阳性对照)

KB人口腔表皮样癌细胞 KB human oral epidermoid carcinoma cells MEM培养基(GIBCO)+10%FBSRPMI-1640(GIBCO)+10%FBS

CM-H028人淋巴内皮细胞完全培养基100mL

人表皮淋巴内管皮细胞(HDLEC)(5×105) 人星形胶质细胞 Human

技术外包服务:

★凝血酶(凝血因子II)轻链抗体品牌 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。